Epidemiological characteristics of lower extremity arterial disease in Chinese diabetes patients at high risk: a prospective, multicenter, cross-sectional study

医学 糖尿病 血脂异常 横断面研究 流行病学 内科学 血压 指南 血糖性 物理疗法 疾病 内分泌学 病理
作者
Xiaomei Zhang,Xingwu Ran,Zhangrong Xu,Zhifeng Cheng,Feixia Shen,Yanmei Yu,Lin Gao,Sanbo Chai,Changjiang Wang,Jianying Liu,Jing Liu,Zilin Sun,Jiajun Zhao,Linong Ji
出处
期刊:Journal of Diabetes and Its Complications [Elsevier BV]
卷期号:32 (2): 150-156 被引量:41
标识
DOI:10.1016/j.jdiacomp.2017.10.003
摘要

Abstract Aims To determine the epidemiological characteristics of lower extremity arterial disease (LEAD) in high-risk patients and identify practical gaps in LEAD management. Methods This cross-sectional study consecutively enrolled 10681 patients with type 2 diabetes from 30 hospitals across China from June 2016 to January 2017. All patients were assessed for LEAD by the Ankle-Brachial Index in conjunction with lower limb ultrasonography according to local guidelines. Results The mean age of patients was 64.2 years, and the median duration of diabetes was 9.0 years. The overall prevalence of LEAD was 21.2%, with 10.6% of patients diagnosed with LEAD before enrollment and 11.8% newly diagnosed at the present visit. Patients with older age, hypertension and dyslipidemia as well as those who smoked were at higher risk of developing LEAD. Only 55.0%, 28.2%, and 42.5% of participating patients reached the guideline-recommended goals for glycemic, blood pressure, and lipid control, respectively. Anti-hypertensive agents, lipid lowering therapies, anti-platelet agents, and vasodilators were underused, especially in newly diagnosed LEAD patients (44.1%, 46.2%, 35.3%, and 31.7%, respectively). Conclusions Despite the high prevalence of LEAD, it was still found to be underdiagnosed and undertreated in Chinese diabetes patients. More efforts should be directed at encouraging awareness of early LEAD and achieving guideline-recommended goals in type 2 diabetes patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无花果应助ytt采纳,获得10
1秒前
科目三应助干雅柏采纳,获得10
1秒前
2秒前
2秒前
个性的孤风完成签到,获得积分10
3秒前
李健的小迷弟应助ccccc采纳,获得10
3秒前
华仔应助forever采纳,获得10
5秒前
顺利晓露完成签到,获得积分20
5秒前
5秒前
happy完成签到,获得积分10
7秒前
7秒前
852应助xie采纳,获得30
8秒前
8秒前
9秒前
hhhblabla应助清爽山蝶采纳,获得10
9秒前
香蕉麦片完成签到 ,获得积分10
9秒前
Owen应助seven采纳,获得10
10秒前
12秒前
obcx完成签到,获得积分10
13秒前
Mencanta完成签到,获得积分10
13秒前
干雅柏发布了新的文献求助10
14秒前
Helium完成签到,获得积分10
15秒前
韩凡发布了新的文献求助10
16秒前
16秒前
18秒前
志堂真辉完成签到,获得积分10
18秒前
小二郎应助杨杨杨采纳,获得10
19秒前
DJ完成签到,获得积分10
21秒前
ccccc发布了新的文献求助10
22秒前
小蘑菇应助csl采纳,获得10
23秒前
小乔发布了新的文献求助10
24秒前
小宇子发布了新的文献求助10
24秒前
爱听歌土豆完成签到,获得积分10
25秒前
科研通AI5应助小瑶采纳,获得10
25秒前
xiaoshuwang完成签到,获得积分10
26秒前
非要叫我起个昵称完成签到,获得积分10
28秒前
28秒前
LYQ完成签到,获得积分10
29秒前
端庄的煎蛋完成签到,获得积分0
30秒前
炸茄盒的老头完成签到,获得积分10
33秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Ophthalmic Equipment Market 1500
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
いちばんやさしい生化学 500
The First Nuclear Era: The Life and Times of a Technological Fixer 500
Unusual formation of 4-diazo-3-nitriminopyrazoles upon acid nitration of pyrazolo[3,4-d][1,2,3]triazoles 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3672312
求助须知:如何正确求助?哪些是违规求助? 3228717
关于积分的说明 9781603
捐赠科研通 2939143
什么是DOI,文献DOI怎么找? 1610605
邀请新用户注册赠送积分活动 760682
科研通“疑难数据库(出版商)”最低求助积分说明 736174